Vitaccess Real CIDP Registry
NCT07006597 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2025-06-05
Summary
Vitaccess Real CIDP (VRCIDP) is a patient registry designed to capture longitudinal observational data on chronic inflammatory demyelinating polyneuropathy (CIDP), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 300 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from electronic medical records (EMR). Patient reported and eCRF data will be linked via a unique ID and PIN assigned to each participant at enrolment.
Patients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.
Conditions
Sponsors & Collaborators
-
Vitaccess Ltd
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-31
- Primary Completion
- 2035-07-31
- Completion
- 2035-07-31
More Related Trials
-
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128 ·Status: RECRUITING ·Phase: PHASE3
-
Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
NCT06389721 ·Status: RECRUITING
-
Surgical Treatment of Chronic Neuropathic Pain
NCT04287075 ·Status: TERMINATED
-
Understanding Risk Factors and Determinants for Neuropathic Pain
NCT02402361 ·Status: COMPLETED
-
Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
NCT02574962 ·Status: WITHDRAWN ·Phase: PHASE2
-
sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN
NCT02271724 ·Status: UNKNOWN
-
BlueWind Medical Reprieve System for the Treatment of PNP
NCT02062398 ·Status: COMPLETED ·Phase: NA
-
Medtronic Inceptiv™ Closed-Loop DTM Spinal Cord Stimulation for Painful Diabetic Peripheral Neuropathy
NCT07209514 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain
NCT00375960 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study in Patients With Refractory Chronic Lower Limb Neuropathic Pain and/or Back Neuropathic Pain.
NCT04852107 ·Status: TERMINATED ·Phase: NA
-
Economic Medical Evaluation of Treatment of the Neuropathic Pain Rebel by Cortical Stimulation
NCT00241566 ·Status: COMPLETED ·Phase: PHASE4
-
A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
NCT06203002 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain
NCT01053845 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT00603265 ·Status: COMPLETED ·Phase: PHASE2
-
Pain-related Evoked Potentials in Unilateral Peripheral Nerve Injuries
NCT03082820 ·Status: COMPLETED
-
StimRouter Registry Clinical Protocol
NCT03913689 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy
NCT03304522 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy
NCT03339336 ·Status: TERMINATED ·Phase: PHASE2
-
Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
NCT00322621 ·Status: COMPLETED ·Phase: PHASE4
-
NTX-001 to Repair Peripheral Nerve Transection(s)
NCT05565846 ·Status: AVAILABLE
-
Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)
NCT00592904 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Pilot Study to Explore the Use of Skin Biopsy as Diagnostic Tool in Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)
NCT05678127 ·Status: UNKNOWN ·Phase: NA
-
A Post Market Cohort With the Spinal Modulation Neurostimulator System in Peripheral Neuropathy
NCT02349646 ·Status: TERMINATED
-
To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
NCT05581199 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2